Table 1. Examples of genetically engineered cellular nanoparticle platforms.
Cell type | Modification | Engineering method |
Application | Ref. |
---|---|---|---|---|
Nanodelivery | ||||
Primary T cell | Anti-glypican 3 CAR | Lentiviral transduction | Delivery of photothermal agent to hepatocellular carcinoma cells | [67] |
C1498 (acute myeloid leukemia) | VLA-4 | Retroviral transduction | Targeting VCAM-1 in inflammation sites and delivery of dexamethasone | [59] |
Adipose-derived stem cell | CXCR4 | Retroviral transduction | Targeting SDF-1 in inflammation sites and delivery of VEGF | [148] |
Neural stem cell | CXCR4 | Lentiviral transduction | Targeting SDF-1 in inflammation sites and delivery of VEGF through the blood–brain barrier | [149] |
B16F10 (melanoma) | Influenza HA | Lipid-based transfection | Improved endosomal escape for increased cytosolic delivery | [98] |
Dendritic cell | IL-4 | Adenovirus transduction | Delivery of IL-4 to suppress inflammation in arthritis | [68] |
Cancer immunotherapy | ||||
E. coli (OMV) | Cytolysin A-SpyCatcher | Bacterial transformation | Presentation of tumor antigens alongside immunostimulatory OMVs | [66] |
Cytolysin A-SnoopCatcher | ||||
B16F10 (melanoma) | CD80 | Lipid-based transfection | Direct activation of tumor-targeting T cells | [166] |
HEK293T | PD-1 | Lipid-based transfection | Targeting to PD-L1 on melanoma cells and delivery of anti-immunosuppressive molecules | [60] |
Platelet | PD-1 | Lentiviral transduction | Reversal of T cell exhaustion in post-surgical cancer sites | [183] |
Vaccination against pathogens | ||||
S. aureus | Deletion of agr locus | Bacterial transformation | Broad-spectrum protection against dengue virus | [193] |
Dengue virus antigens | ||||
E. coli (OMV) | Glycan epitope associated with N. meningitidis infection | Bacterial transformation | Protection against N. meningitidis | [198] |
E. coli (OMV) | F. tularensis O-antigen polysaccharide | Bacterial transformation | Protection against F. tularensis | [199] |
E. coli (OMV) | Omp22-Cytolysin A | Bacterial transformation | Protection against A. baumannii | [199] |
Detoxification | ||||
HEK293T | ACE2 | Lipid-based transfection | Detoxification of SARS-CoV-2 to prevent infection | [57] |